Burning Rock
In Brief This Week: Biocartis, Quest Diagnostics, OpGen, More
News items for the week of Jan. 16, 2023.
In Brief This Week: Thermo Fisher Scientific, Burning Rock, DermTech, More
News items for the week of Jan. 2, 2023.
Burning Rock Biotech Q3 Revenues Climb 22 Percent
The company said in-hospital test sales have continued to grow, alongside it's newest MRD LDT, but COVID headwinds portend a leaner fourth quarter.
360Dx Top 30 Tumbles in August
Of the 30 diagnostic companies in the index, 22 saw their share prices decline, while eight firms saw stock prices rise.
Burning Rock Q2 Revenues Grow 3 Percent Despite Local COVID-19 Impact
The Chinese cancer molecular diagnostics company saw strong growth in pharma services during the quarter but decreased hospital test sales.
Jul 1, 2022
360Dx Top 30 Drops 5 Percent in June
May 31, 2022
Burning Rock Biotech Q1 Revenues up 27 Percent
Apr 1, 2022
360Dx Top 30 Falls Slightly in March
Mar 22, 2022
Burning Rock Q4 Revenues up 12 Percent
Jan 4, 2022
360Dx Index Rises 20 Percent in 2021
Nov 17, 2021
Nov 16, 2021
Burning Rock Q3 Revenues Inch up 2 Percent
Aug 31, 2021